Dennis Lanfear is President, Chief Executive Officer and Chairman of the Board of Directors of Coherus Oncology, Inc. (CHRS). The company reported total compensation of $2,736,874 for fiscal year 2025.
| Salary | $1,026,545 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $828,130 |
| Non-equity incentive plan | $869,295 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $12,904 |
| Total | $2,736,874 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Coherus Oncology, Inc. filed April 20, 2026, accession 0001104659-26-045251.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President, Chief Executive Officer and Chairman of the Board of Directors | $1,026,545 | $0 | $0 | $828,130 | $869,295 | $0 | $12,904 | $2,736,874 |
| FY2024 | President, Chief Executive Officer and Chairman of the Board of Directors | $1,013,410 | — | $2,873,088 | $902,184 | — | — | $13,627 | $4,802,309 |
Totals as disclosed in each year's own compensation disclosure for Coherus Oncology, Inc..
| Peer-group chief executive median | $5,227,168 |
|---|---|
| Difference from that median | $-2,490,293 |
| Percentile within the disclosed peer group | 28th |
| Peers with a disclosed figure | 34 |
Medians and percentiles are computed across the peer group Coherus Oncology, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Dennis Lanfear this page | President, Chief Executive Officer and Chairman of the Board of Directors | $2,736,874 |
| Paul Reider | Former Chief Commercial Officer | $1,227,524 |
| Bryan McMichael | Chief Financial Officer | $1,103,077 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Coherus Oncology, Inc. compensation brief.
Dennis Lanfear's compensation sits inside Coherus Oncology, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.